This leads to insulin resistance, pancreatic β-cell dysfunction, and reduced insulin synthesis via inhibition of pancreatic duodenal homeobox-1 (PDX-1) and glucose transporter type 2 (GLUT2), ultimately contributing to hyperglycemia and type 2 diabetes mellitus (T2DM). This evidence concerns the gene SLC2A2 and type 2 diabetes mellitus.